Psychedelics Coursesby Blossom
ProfessionalHybridActive

Upcoming Fundamentals Training

TheraPsil’s Upcoming Fundamentals Training page lists upcoming psilocybin and MDMA fundamentals cohorts, with online and in-person options. Individual listings include practical details such as facilitators, tuition or early-bird pricing where available, and language options.

Provider

TheraPsil

English and French

Schedule

Dates not announced

Enrollment

Tuition and early-bird pricing vary by cohort; examples listed include $4,999, $

Decision Summary

Best fit
Applicants interested in psychedelic-assisted psychotherapy training, including psilocybin and MDMA program participants.
Format
Hybrid
Time commitment
Not listed
Credential signal
Not listed

Course Overview

TheraPsil’s Upcoming Fundamentals Training page is a directory of upcoming psychedelic-assisted psychotherapy training cohorts focused on psilocybin and MDMA. The listings include online psilocybin options as well as in-person MDMA and psilocybin intensives in several cities. The page appears aimed at professionals interested in psychedelic-assisted psychotherapy training. Cohorts are described individually rather than through a single unified curriculum, so details such as duration, schedule, and pricing vary by listing. Where provided, the page includes practical information such as facilitators, tuition or early-bird pricing, and language options. Psilocybin cohorts are offered in English and French, and one online option is described as using Aotearoa New Zealand–friendly timing with NZ-specific teaching.

Who is this for?

Applicants interested in psychedelic-assisted psychotherapy training, including psilocybin and MDMA program participants.

About the Provider

TheraPsil is a Canadian nonprofit focused on legal access to psychedelic-assisted therapy for people in medical need. Its current public work spans patient navigation, prescriber and therapist training, referrals, and sustained advocacy around federal access pathways. The organization remains one of the clearest Canadian patient-access stakeholders because it links policy work to concrete care pathways. Current materials show active work on Project Solace, ongoing clinician upskilling, and new Manitoba progress around MDMA-assisted therapy.

View all TheraPsil courses

Course FAQ

Who is this course for?

Applicants interested in psychedelic-assisted psychotherapy training, including psilocybin and MDMA program participants.

What is the format and time commitment?

Format: Hybrid.

How much does it cost?

The listed price is Tuition and early-bird pricing vary by cohort; examples listed include $4,999, $. Confirm the latest tuition, fees, and payment options on the provider website.

Are dates currently announced?

This active course does not have a listed upcoming cohort date yet. Check the provider website for current schedule details.

Is this course currently available?

The current listing status is Active. Use the provider website for the latest enrollment status.

Related Courses

View all courses